US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avid Bioservices, Inc.

12.49

+0.0000

Volume:- -

Turnover:38.32M

Market Cap:798.90M

PE:-5.22

High:12.49

Open:12.49

Low:12.49

Close:12.49

Loading ...

Overview Company News Filings

Microbix Advances Kinlytic Urokinase Production with New CDMO Agreement

Press Release: Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining

QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

Combined General Meeting of May 21, 2025 - Availability of preparatory documents

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

Santhera Full Year Results for the Year Ended 31 December 2024

Press Release: Integer Announces CEO Succession Plan

Integer Holdings Corporation Reports First Quarter 2025 Results

Press Release: Samsung Biologics reports first quarter 2025 financial results

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release: Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Preliminary results for the year ended 31 December 2024

Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward

FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25…

Zacks Small Cap Research

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Made in Australia: ASX firms boosting local health and medical manufacturing

Availability of the 2024 Universal Registration Document, including the Annual Financial Report

Lantheus Completes Acquisition of Evergreen Theragnostics

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CDMO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDMO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.49,"timestamp":1738702800000,"preClose":12.49,"halted":3,"volume":0,"delay":0,"floatShares":50623090,"shares":63963302,"eps":-2.394638,"marketStatus":"Halted","change":0,"latestTime":"05-07 19:19:22 EDT","open":12.49,"high":12.49,"low":12.49,"amount":38317107.960278,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.394638,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746662400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.49,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","floatShares":50623090,"roa":"-3.27%","roe":"-133.29%","lyrEps":-2.227139,"shares":63963302,"dividePrice":0,"high":12.49,"amplitude":0,"preClose":12.49,"low":12.49,"week52Low":5.9,"pbRate":"17.83","psRate":"5.31","week52High":12.51,"institutionHeld":0.9807,"latestPrice":12.49,"eps":-2.394638,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.394638,"open":12.49,"prevYearClose":12.35,"prevWeekClose":12.48,"prevMonthClose":12.48,"prevQuarterClose":12.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDMO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533865775","title":"Microbix Advances Kinlytic Urokinase Production with New CDMO Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2533865775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533865775?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446431,"startTime":"0","endTime":"0","summary":"Microbix Biosystms ( ($TSE:MBX) ) has shared an update. Microbix Biosystems Inc. announced that its partner, Sequel Pharma, has signed an agreement...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/microbix-advances-kinlytic-urokinase-production-with-new-cdmo-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/microbix-advances-kinlytic-urokinase-production-with-new-cdmo-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","CDMO","MBX"],"gpt_icon":0},{"id":"2532018422","title":"Press Release: Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining","url":"https://stock-news.laohu8.com/highlight/detail?id=2532018422","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532018422?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:46","pubTimestamp":1746053160,"startTime":"0","endTime":"0","summary":"Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining. SAN ANTONIO, April 30, 2025  -- Scorpius Holdings, Inc  , an integrated contract development and manufacturing organization , today provided strategic, financial, and operational updates for the year ended December 31, 2024.Jeff Wolf, CEO of Scorpius Holdings, Inc., stated, \"The current biotech funding environment has created real headwinds for many of our clients, particularly when it comes to advancing drug development and clinical trials. In response, we took decisive steps to streamline our operations, reduce our cost structure, and refocus on our core CDMO capabilities. While the delay in our Form 10-K filing was not ideal, it was driven in part by the internal realignment necessary to secure our long-term success. With the filing now complete, we are focused on executing our business strategy and driving value for shareholders.\". As of December 31, 2024, th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CDMO","SCPX"],"gpt_icon":0},{"id":"2531794253","title":"QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2531794253","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531794253?lang=en_us&edition=fundamental","pubTime":"2025-04-30 04:05","pubTimestamp":1745957100,"startTime":"0","endTime":"0","summary":"QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene therapy manufacturing. Expansion underscores the commitment of QIAGEN to help accelerate the development of safe and effective biotherapeutics. New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow. VENLO, the Netherlands, April 29, 2025----QIAGEN  today announced the expansion of its cell and gene therapy  portfolio with an enhanced digital PCR  workflow that now includes solutions for lentivirus-based applications, commonly used in the production of advanced treatments such as chimeric antigen receptor T-cell , a personalized form of cancer immunotherapy.\"Cell and gene therapy developers face increasing demands for precise, scalable solutions to help ensure therapy safety and efficacy,\" said Justus Krause-Harder, Vice President and Head of Molecular Tools & Oncology at QIAGE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qiagen-expands-digital-pcr-portfolio-200500493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RCL","LU1366192091.USD","BK4139","BK4517","LU0266013472.USD","LU2125909247.SGD","BK4142","LU2125909593.SGD","BK4585","CDMO","LU1923622614.USD","LU2433249047.HKD","BK4566","BK4588","QGEN","BK4121"],"gpt_icon":0},{"id":"2531686277","title":"Combined General Meeting of May 21, 2025 - Availability of preparatory documents","url":"https://stock-news.laohu8.com/highlight/detail?id=2531686277","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531686277?lang=en_us&edition=fundamental","pubTime":"2025-04-29 23:40","pubTimestamp":1745941200,"startTime":"0","endTime":"0","summary":"Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 21, 2025 at 10:30 a.m.  at 15 bis, rue Traversière 75012 Paris. The notice of meeting was published at the French official legal announcement publication  on Wednesday April 16, 2025 and the convening notice  was published in the Actu-juridique.fr, a French journal of legal notice, on April 28, 2025.Registered shareholders can request, within the legal and regulatory deadlines, additional documents, by email at ir@euroapi.com, or by request to the Company's registered office at 15, rue Traversière 75012 Paris.About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Develo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/combined-general-meeting-may-21-154000666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CET","BK4139","CDMO","EAPIF","BK4007"],"gpt_icon":0},{"id":"2531781914","title":"ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2531781914","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531781914?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924400,"startTime":"0","endTime":"0","summary":"\"As we ramp up clinical manufacturing and advance towards commercialization of MB-105, scalability continues to be an important focal point. This grant will enable continued development of a robust cGMP process with the G-Rex bioreactor to further reduce complexity, time, and costs incurred with manufacturing autologous CAR-T products,\" says Dr. Maksim Mamonkin, Chief Scientific Officer at March Biosciences.\"We understand how to overcome the scalability and efficiency barriers that March Biosciences faced with manufacturing an autologous CAR-T product and are happy to help March Biosciences establish nimble MB-105 manufacturing with a G-Rex Grant\" said John Wilson, CEO of Wilson Wolf and co-inventor of G-Rex.As part of the G-Rex Grant, March Biosciences will continue development of a G-Rex-centric fully integrated CAR-T cell manufacturing process to further streamline the scalable cGMP production of MB-105 and other CAR-T products in the research pipeline.For more information about the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/scaleready-announces-march-biosciences-recipient-110000510.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scaleready-announces-march-biosciences-recipient-110000510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64QTZ34.USD","CDMO","BK4022","REXX","BK4585","BK4588","BK4139","IE00B19Z6F94.USD","BK4121","TECH","IE0034390439.USD","BK4230","CAR"],"gpt_icon":0},{"id":"2531247524","title":"Santhera Full Year Results for the Year Ended 31 December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2531247524","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531247524?lang=en_us&edition=fundamental","pubTime":"2025-04-29 13:00","pubTimestamp":1745902800,"startTime":"0","endTime":"0","summary":"Transformational year following the successful launch of AGAMREE. Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals  today announces its full year results for the year ended 31 December 2024.Other EU direct markets progressing well: Following a positive recommendation for AGAMREE from the National Institute for Health and Care Excellence  in the UK in December 2024, full launch was achieved in Q2 2025. Launches are expected to follow in other major EU countries throughout 2025 and the first half 2026.Catalyst successfully launched in the U.S.: Catalyst launched AGAMREE in the U.S. in March 2024 and reported USD 46 million revenue for the calendar year, exceeding its upgraded guidance for the year. Catalyst has provided sales guidance in excess of USD 100 million for 2025, which would trigger a further milestone to Santhera in addition to the ongoing royalty income.Rollout in other territories: Santhera signed additional agreements during the year to expand AGAMREE’s acce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/santhera-full-results-ended-31-050000174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU2346227817.USD","IE00B7SZL793.SGD","BK4139","BK4145","LU1894683348.USD","CTS","IE00BFMHRM44.USD","BK4543","CDMO","IE00B19Z4B17.USD","BK4208","LU1894683264.USD","IE00B66KJ199.SGD","BK4566","LU2637428348.USD","CMS","SPHDF","IE0031619046.USD","NICE","BK4585","LU2500361329.USD","BK4023"],"gpt_icon":0},{"id":"2529986982","title":"Press Release: Integer Announces CEO Succession Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2529986982","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529986982?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:01","pubTimestamp":1745496060,"startTime":"0","endTime":"0","summary":"Payman Khales appointed President and CEO effective October 24, 2025. \"It has been an honor to lead the Integer team through this pivotal period in our Company's history, and I am proud of what we have accomplished for our customers and patients around the world,\" said Mr. Dziedzic. \"Payman is the natural choice to guide Integer through our next chapter of growth. He is an exceptional leader who embodies our commitment to innovation, quality and operational excellence, and his track record speaks for itself. Payman has been an integral part of the development and execution of our strategy, both within Cardio & Vascular and across the enterprise, while leading Integer's Customer Operational Strategic Imperatives. I look forward to the Company's continued success under Payman's leadership.\". \"I am honored to be named the next CEO of Integer and would like to thank Joe and the Board of Directors for having faith in me to lead this amazing company in its n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","LU0757428866.USD","ITGR","LU1559883803.SGD","BK4022","LU1815336091.USD","BK4082","CDMO","LU0128526141.USD","LU0566484027.USD","LU1169589451.USD","LU0029874061.USD","BK4139","LU1169590202.USD","BK4232"],"gpt_icon":0},{"id":"2529488937","title":"Integer Holdings Corporation Reports First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2529488937","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529488937?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"~ Strong start to the year with 1Q25 financial results ~~ Reiterating 2025 sales and adjusted operating income outlook; raising adjusted EPS outlook ~PLANO, Texas, April 24, 2025  -- Integer Holdings Corporation  today announced results for the three months ended March28, 2025.GAAP operating income increased $11 million to $50 million, an increase of 28%. Non-GAAP adjusted operating income increased $9 million to $71 million, an increase of 14%.GAAP income  from continuing operations decreased $43 million to a $22 million loss, primarily from debt conversion inducement expense related to the exchange of 2028 convertible notes. Non-GAAP adjusted net income increased $7 million to $46 million, an increase of 19%.GAAP diluted EPS from continuing operations decreased $1.25 to a loss of $0.66. Non-GAAP adjusted EPS increased $0.17 to $1.31.Other Markets sales decreased 37% in the first quarter 2025 compared to the first quarter 2024, primarily driven by the planned multi-year Portable Medic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integer-holdings-corporation-reports-first-120000069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU0757428866.USD","LU0029874061.USD","LU1559883803.SGD","LU1169589451.USD","LU1815336091.USD","ITGR","BK4082","CDMO","LU0128526141.USD","LU1169590202.USD","LU0566484027.USD"],"gpt_icon":0},{"id":"2529544366","title":"Press Release: Samsung Biologics reports first quarter 2025 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2529544366","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529544366?lang=en_us&edition=fundamental","pubTime":"2025-04-23 14:46","pubTimestamp":1745390760,"startTime":"0","endTime":"0","summary":"-- Recorded Q1'25 consolidated revenue of KRW 1.3 trillion. INCHEON, South Korea, April 23, 2025 /PRNewswire/ -- Samsung Biologics , a global contract development and manufacturing organization , today announced financial results for the first quarter of fiscal year 2025.\"We sustained solid momentum in the first quarter, supported by the efficient operations across all our plants and continued partnerships with our clients,\" said John Rim, CEO and President of Samsung Biologics. \"The launch of Plant 5 and our dedicated antibody-drug conjugate  facility marks another milestone in expanding our capacity to cater to diverse client demands. We remain committed to delivering long-term value for clients and shareholders through strategic investments in technology while continuously offering competitive advantages with our development and manufacturing capabilities.\". Plans to build a sixth plant in response to growing biomanufacturing demand are currently awaiting board approval. Samsung Bio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139","ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2529372791","title":"Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2529372791","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529372791?lang=en_us&edition=fundamental","pubTime":"2025-04-22 19:00","pubTimestamp":1745319600,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., April 22, 2025  -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , today announced that the company will participate in the upcoming CDMO Live 2025 conference. Billed as a premiere partnering event for the biopharma outsourcing industry, CDMO Live will take place May 7-8, 2025, in Rotterdam, Netherlands.During the conference, Jackie Klecker, Lifecore’s executive vice president, quality and development services, will chair a discussion featuring external quality leaders from the CDMO industry. The talk will explore approaches for transforming quality management from a potential bottleneck into a strategic driver of CDMO partnerships. Ms. Klecker is well-positioned to lead the discussion based on her more than 30 years of industry experience in quality, manufacturing, and development, including guiding Lifecore’s quality assurance for over a decade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lifecore-biomedical-participate-upcoming-cdmo-110000299.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDMO","LFCR","CFO","BK4212","BK4121","BK4139"],"gpt_icon":0},{"id":"2528206837","title":"Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528206837","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528206837?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:05","pubTimestamp":1744833900,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., April 16, 2025  -- Lifecore Biomedical, Inc.   a fully integrated contract development and manufacturing organization , today announced that Lifecore granted a restricted stock unit  award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stock, an RSU for 170,000 shares of common stock, and a performance stock unit  award for up to 370,000 shares of its common stock to Thomas D. Salus, Lifecore’s newly hired chief legal and administration officer. The RSU awards, stock option and PSU award were granted April 14, 2025, pursuant to an employment agreement between Lifecore and Mr. Salus, and as a material inducement to Mr. Salus joining Lifecore as its chief legal and administration officer.About Lifecore BiomedicalLifecore Biomedical, Inc.  is a fully integrated contract development and manufacturing organization  that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical product","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lifecore-announces-inducement-grants-under-200500441.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4139","LU2210150020.SGD","BK4588","CFO","IE00B64PRP62.GBP","BK4121","BK4212","IE00BKPKM429.USD","IE00BGHQF748.EUR","LFCR","LU2095319765.USD","NDAQ","CDMO","BK4112","BK4585"],"gpt_icon":0},{"id":"2527302381","title":"Press Release: Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527302381","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527302381?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry. Significantly Elevates Lifecore's Capabilities Across Corporate Governance, Transactional Activities, and SEC Reporting and Compliance. \"Tom's appointment is the latest action by Lifecore to strengthen our organization by adding top-tier talent to our leadership team. Having in-house counsel will be particularly valuable to drive corporate governance and SEC/Nasdaq reporting and compliance as we continue to streamline the processes that impact performance in these areas,\" said Paul Josephs, president and chief executive officer of Lifecore. \"We are excited to bring Tom on board and benefit from his wealth of experience, particularly his deep ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","CDMO","BK4139","BK4121","LFCR","NQmain"],"gpt_icon":0},{"id":"2526352564","title":"Preliminary results for the year ended 31 December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2526352564","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526352564?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:00","pubTimestamp":1744196400,"startTime":"0","endTime":"0","summary":"~ Strong commercial momentum underpins transformative financial performance ~ Strong 2024 financial performance in line with guidance Revenue growth of 44% to 128.8 million compared to 2023, organic r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058256/0/en/Preliminary-results-for-the-year-ended-31-December-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK4229","CFO","AGM","BK4202","CAGR","CET","BK4139","BK4195","ESGR","BK4159","CDMO","BK4019"],"gpt_icon":0},{"id":"2525946268","title":"Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward","url":"https://stock-news.laohu8.com/highlight/detail?id=2525946268","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525946268?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115400,"startTime":"0","endTime":"0","summary":"Serving as a premium partner for pharmaceutical companies by contributing to the safety and productivity of their manufacturing process. TOKYO & NOVI, Mich., & DSSELDORF, Germany, April 08, 2025----To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure. Through this change, the company can offer the industry more agile and focused services, deeper innovation in bioprocess solutions, and stronger support in emerging modalities.\"I am thrilled to announce the start of operations at Asahi Kasei Life Science, which began on April 1,\" said Ken Shinomiya, President of Asahi Kasei Life Science. \"Focused on the field of life science centered on the bioprocess business, we aim to expand as part of the growing Healthcare sector business, the main growth driver of the Asahi Kasei Group. As a trusted premium","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asahi-kasei-establishes-asahi-kasei-123000841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHKSY","CDMO","AHKSF","BK4145","BK4202","BK4090","FORD","BK4139"],"gpt_icon":0},{"id":"2524902992","title":"FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25…","url":"https://stock-news.laohu8.com/highlight/detail?id=2524902992","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524902992?lang=en_us&edition=fundamental","pubTime":"2025-04-03 23:31","pubTimestamp":1743694260,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc.  is continuing preparations for a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers , which we anticipate initiating in the second quarter of 2025 and completing before the end of 2025. Recent activities the company has accomplished to support the upcoming clinical trial include:. The company does not utilize single cell fibroblasts for treatment but instead a fibroblast spheroid, which is composed of approximately 3,000 fibroblasts and is administered to the top of the wound at which time the cells migrate from the surface of the wound and release various cytokines and growth factors to initiate the wound healing process. The use of spheroids is more practical from a therapeutic perspective as they have higher viability than single cells, they don’t require pre-culturing before administra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fblg-phase-1-2-trial-153100735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDMO","BK4139","FBLG","SEPA","EAE"],"gpt_icon":0},{"id":"2524444886","title":"Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2524444886","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524444886?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:05","pubTimestamp":1743624300,"startTime":"0","endTime":"0","summary":"PLANO, Texas, April 02, 2025  -- Integer Holdings Corporation  , a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028  that the Notes are convertible, at the option of the holders  beginning on April1, 2025, and ending at the close of business on June30, 2025. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company’s common stock or a combination thereof, at the Company’s election, in respect of the remainder, if any, of the Company’s conversion obligation in excess of the aggregate principal amount of the Notes being converted. Any determination regarding the convertibility of the Notes during future periods will be made in accordance with the terms of the Indenture governing the Notes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integer-holdings-corporation-announces-conversion-200500630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1815336091.USD","LU0029874061.USD","ITGR","LU0128526141.USD","LU1559883803.SGD","BK4139","CDMO","LU1169589451.USD","LU1169590202.USD","LU0757428866.USD","LU0566484027.USD","BK4082"],"gpt_icon":0},{"id":"2524296891","title":"Made in Australia: ASX firms boosting local health and medical manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524296891","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524296891?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:55","pubTimestamp":1743540941,"startTime":"0","endTime":"0","summary":"Healthcare and medical manufacturing in Australia is gaining momentum supported by initiatives from federal and state governments. CSL, IDT Australia, Optiscan and Trajan Group among healthcare companies with manufacturing facilities in Melbourne. EZZ Life Science said manufacturing in Australia is one of its “biggest selling points” into China and Southeast Asia","market":"nz","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/04/GettyImages-2201248024-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/04/GettyImages-2201248024-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/made-in-australia-asx-firms-boosting-local-health-and-medical-manufacturing/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4139","BK4568","LU0321505439.SGD","SG9999001176.USD","IE00BBT3K403.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4592","LU0122379950.USD","LU1894683264.USD","TGA","LU0321505868.SGD","BK4533","BK4588","LU0225771236.USD","SG9999013999.USD","BK4213","CDMO","LU0456855351.SGD","SG9999002224.SGD","LU1066053197.SGD","LU0306806265.USD","SG9999003800.SGD","BK4581","LU1894683348.USD","LU1883839398.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","BK4585","SGXZ57979304.SGD","LU1066051498.USD","BK4007","LU0225284248.USD","IE00BLSP4239.USD","IE0002270589.USD","LU0058720904.USD","BK4599","LU0868494617.USD","LU1057294990.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999001176.SGD","LU0234572021.USD","SG9999002232.USD","BK4534","LU0985481810.HKD","IE000M9KFDE8.USD","BK4550"],"gpt_icon":1},{"id":"2524149124","title":"Availability of the 2024 Universal Registration Document, including the Annual Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2524149124","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524149124?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:39","pubTimestamp":1743521940,"startTime":"0","endTime":"0","summary":"Paris – April 1, 2025 – EUROAPI announces the publication of its 2024 Universal Registration Document in ESEF format, filed with the French Autorité des marchés financiers  on April 1, 2025.The 2024 Universal Registration Document contains in particular:. The annual financial report, including the management report that encompasses namely the Corporate Governance report, the sustainability statement and the company and consolidated statements;The statutory auditors’ reports, including the special report on the regulated agreements;The disclosures relating to statutory auditors’ fees; and. The disclosures relating to the description of the share buy-back program.About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/availability-2024-universal-registration-document-153900821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4075","BK4007","EAPIF","CDMO","UVV","BK4139"],"gpt_icon":0},{"id":"2524811984","title":"Lantheus Completes Acquisition of Evergreen Theragnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2524811984","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524811984?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:00","pubTimestamp":1743512400,"startTime":"0","endTime":"0","summary":"Through the transaction, Lantheus has acquired OCTEVY, a registrational-stage PET diagnostic imaging agent targeting neuroendocrine tumors, which complements Lantheus’ therapeutic candidate PNT2003, as well as a portfolio of clinical and pre-clinical theranostic pairs. The acquisition also advances Lantheus’ capabilities with the addition of Evergreen’s radioligand therapy manufacturing infrastructure, including a revenue-generating CDMO business.This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are subject to risks and uncertainties and are made pursuan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantheus-completes-acquisition-evergreen-theragnostics-130000370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LNTH","BK4585","BK4139","CDMO","BK4198","BK4588"],"gpt_icon":0},{"id":"2524594972","title":"BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524594972","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524594972?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 Million. CDMO Division Secures Anchor Partnership with Tate & Lyle to Develop Next Generation of Plant-Based Sweeteners. Rehovot, Israel-- - BioHarvest Sciences Inc.   , a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2024.Total revenues for the fourth quarter of 2024 increased 62% year-over-year to $7.3 million, exceeding prior management guidance, with gross margins expanding by 600 basis points to 57% of revenue.Ilan Sobel, CEO of BioHarvest Sciences, said: \"The fourth quarter of 2024 marked another period of strong execution across both our Products and CDMO business units, highlighted by 99% year-over-year revenue growth that consistently exceeded guidance. Our VINIA product lines continued to outper","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-reports-fourth-quarter-200500707.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-reports-fourth-quarter-200500707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDMO","BHST","BK4139","BK4183"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":174,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"CDMO","reason":null,"defaultRemindTime":1738852200000,"announcedDate":"2025-02-04","type":"delisting","dateTimestamp":1738818000000},{"market":"US","date":"2024-12-10","symbol":"CDMO","fiscalQuarterEnding":"2024/10","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1733806800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-09-09","symbol":"CDMO","fiscalQuarterEnding":"2024/07","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1725854400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-07-02","symbol":"CDMO","fiscalQuarterEnding":"2024/04","expectedEps":0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1719892800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-04-24","symbol":"CDMO","fiscalQuarterEnding":"2024/01","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDMO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDMO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDMO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDMO","date":"2025-02-04","current":-5.249997,"percent":0.349064,"low":-236.80087,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"high":9284.394324,"avg":397.880667,"sd":1431.818994,"marketCap":798262008},"quantilePoints":[{"date":"2020-05-08","current":-66.994871,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":359226499},{"date":"2020-05-15","current":-58.462505,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":313475954},{"date":"2020-05-22","current":-55.723721,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":298790594},{"date":"2020-05-29","current":-61.517303,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":329855779},{"date":"2020-06-05","current":-67.942912,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":364309893},{"date":"2020-06-12","current":-60.463924,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":324207563},{"date":"2020-06-19","current":-59.305208,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":317994527},{"date":"2020-06-26","current":-62.465344,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":334939173},{"date":"2020-07-02","current":-38.876487,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":406881316},{"date":"2020-07-10","current":-37.526609,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":392753493},{"date":"2020-07-17","current":-40.523339,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":424117261},{"date":"2020-07-24","current":-36.662687,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":383711686},{"date":"2020-07-31","current":-40.06438,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":419313801},{"date":"2020-08-07","current":-41.738229,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":436832302},{"date":"2020-08-14","current":-45.841858,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":479780886},{"date":"2020-08-21","current":-45.031931,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":471304191},{"date":"2020-08-28","current":-45.916081,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":480557704},{"date":"2020-09-04","current":-149.319573,"twenty":-67.942912,"median":-6.237055,"eighty":-2.504068,"marketCap":384049943},{"date":"2020-09-11","current":-158.01246,"twenty":-68.84612,"median":-6.237055,"eighty":-2.504068,"marketCap":406408046},{"date":"2020-09-18","current":-174.517939,"twenty":-69.166335,"median":-6.273961,"eighty":-2.504068,"marketCap":448860140},{"date":"2020-09-25","current":-165.054798,"twenty":-69.619972,"median":-6.314377,"eighty":-2.504068,"marketCap":424520940},{"date":"2020-10-02","current":-165.054798,"twenty":-70.073609,"median":-6.352234,"eighty":-2.504068,"marketCap":424520940},{"date":"2020-10-09","current":-176.938743,"twenty":-70.407166,"median":-6.396225,"eighty":-2.504068,"marketCap":455086447},{"date":"2020-10-16","current":-176.278524,"twenty":-70.847461,"median":-6.421583,"eighty":-2.504068,"marketCap":453388363},{"date":"2020-10-23","current":-180.459912,"twenty":-71.381152,"median":-6.5323,"eighty":-2.504068,"marketCap":464142894},{"date":"2020-10-30","current":-159.552971,"twenty":-71.701366,"median":-6.587659,"eighty":-2.504068,"marketCap":410370242},{"date":"2020-11-06","current":-183.761008,"twenty":-72.235057,"median":-6.662048,"eighty":-2.504068,"marketCap":472633313},{"date":"2020-11-13","current":-196.305173,"twenty":-73.622653,"median":-6.679923,"eighty":-2.504068,"marketCap":504896904},{"date":"2020-11-20","current":-197.845684,"twenty":-75.073301,"median":-6.772187,"eighty":-2.504068,"marketCap":508859100},{"date":"2020-11-27","current":-196.745319,"twenty":-76.904852,"median":-6.782203,"eighty":-2.504068,"marketCap":506028960},{"date":"2020-12-04","current":4498.158592,"twenty":-77.30512,"median":-6.772187,"eighty":-2.483106,"marketCap":638738520},{"date":"2020-12-11","current":4438.917085,"twenty":-77.30512,"median":-6.716829,"eighty":-2.406889,"marketCap":630326226},{"date":"2020-12-18","current":4853.303049,"twenty":-77.30512,"median":-6.716829,"eighty":-2.282345,"marketCap":689169033},{"date":"2020-12-24","current":4857.56781,"twenty":-77.30512,"median":-6.716829,"eighty":-2.161884,"marketCap":689774629},{"date":"2020-12-31","current":4921.539296,"twenty":-77.30512,"median":-6.716829,"eighty":-2.109644,"marketCap":698858580},{"date":"2021-01-08","current":5608.166528,"twenty":-77.30512,"median":-6.716829,"eighty":-2.071578,"marketCap":796359647},{"date":"2021-01-15","current":5770.227613,"twenty":-77.30512,"median":-6.716829,"eighty":-2.052613,"marketCap":819372321},{"date":"2021-01-22","current":6077.290725,"twenty":-77.30512,"median":-6.716829,"eighty":-2.039121,"marketCap":862975283},{"date":"2021-01-29","current":6222.292746,"twenty":-77.30512,"median":-6.716829,"eighty":-2.028206,"marketCap":883565570},{"date":"2021-02-05","current":7774.667359,"twenty":-77.30512,"median":-6.716829,"eighty":-2.00864,"marketCap":1104002765},{"date":"2021-02-12","current":7642.459634,"twenty":-77.30512,"median":-6.716829,"eighty":-1.981915,"marketCap":1085229268},{"date":"2021-02-19","current":7616.871042,"twenty":-77.30512,"median":-6.716829,"eighty":-1.967528,"marketCap":1081595688},{"date":"2021-02-26","current":8776.887239,"twenty":-77.30512,"median":-6.716829,"eighty":-1.953306,"marketCap":1246317988},{"date":"2021-03-05","current":7574.223387,"twenty":-77.331805,"median":-6.744508,"eighty":-1.945514,"marketCap":1075539721},{"date":"2021-03-12","current":236.593569,"twenty":-77.331805,"median":-6.744508,"eighty":-1.937875,"marketCap":1053551161},{"date":"2021-03-19","current":246.292266,"twenty":-77.331805,"median":-6.744508,"eighty":-1.928906,"marketCap":1096739459},{"date":"2021-03-26","current":230.173304,"twenty":-77.278436,"median":-6.698376,"eighty":-1.924277,"marketCap":1024961724},{"date":"2021-04-01","current":262.001423,"twenty":-77.278436,"median":-6.698376,"eighty":-1.907206,"marketCap":1166692337},{"date":"2021-04-09","current":264.870052,"twenty":-77.30512,"median":-6.716829,"eighty":-1.906724,"marketCap":1179466340},{"date":"2021-04-16","current":261.72822,"twenty":-77.30512,"median":-6.716829,"eighty":-1.903436,"marketCap":1165475765},{"date":"2021-04-23","current":289.594899,"twenty":-77.30512,"median":-6.716829,"eighty":-1.897813,"marketCap":1289566086},{"date":"2021-04-30","current":292.395227,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1302035947},{"date":"2021-05-07","current":277.300776,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1234820356},{"date":"2021-05-14","current":274.432148,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1222046353},{"date":"2021-05-21","current":274.295546,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888362,"marketCap":1221438067},{"date":"2021-05-28","current":290.68771,"twenty":-77.30512,"median":-6.716829,"eighty":-1.871961,"marketCap":1294432373},{"date":"2021-06-04","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.85901,"marketCap":1407573549},{"date":"2021-06-11","current":315.68576,"twenty":-77.30512,"median":-6.716829,"eighty":-1.848648,"marketCap":1405748691},{"date":"2021-06-18","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.841619,"marketCap":1407573549},{"date":"2021-06-25","current":342.869433,"twenty":-77.30512,"median":-6.716829,"eighty":-1.832157,"marketCap":1526797583},{"date":"2021-07-02","current":142.499473,"twenty":-77.30512,"median":-6.716829,"eighty":-1.830139,"marketCap":1597704096},{"date":"2021-07-09","current":141.845556,"twenty":-77.30512,"median":-6.716829,"eighty":-1.821934,"marketCap":1590372376},{"date":"2021-07-16","current":136.83219,"twenty":-77.30512,"median":-6.716829,"eighty":-1.81215,"marketCap":1534162518},{"date":"2021-07-23","current":141.355118,"twenty":-77.30512,"median":-6.716829,"eighty":-1.799525,"marketCap":1584873585},{"date":"2021-07-30","current":139.774818,"twenty":-77.30512,"median":-6.716829,"eighty":-1.785372,"marketCap":1567155261},{"date":"2021-08-06","current":141.73657,"twenty":-77.30512,"median":-6.716829,"eighty":-1.764864,"marketCap":1589150422},{"date":"2021-08-13","current":136.723204,"twenty":-77.30512,"median":-6.716829,"eighty":-1.688839,"marketCap":1532940565},{"date":"2021-08-20","current":135.142904,"twenty":-77.30512,"median":-6.716829,"eighty":-1.617566,"marketCap":1515222240},{"date":"2021-08-27","current":132.180722,"twenty":-77.30512,"median":-6.716829,"eighty":-1.602452,"marketCap":1482010253},{"date":"2021-09-03","current":126.490823,"twenty":-77.30512,"median":-6.716829,"eighty":-1.594862,"marketCap":1418215110},{"date":"2021-09-10","current":101.036419,"twenty":-77.30512,"median":-6.716829,"eighty":-1.573195,"marketCap":1291851653},{"date":"2021-09-17","current":100.652615,"twenty":-77.30512,"median":-6.716829,"eighty":-1.534217,"marketCap":1286944334},{"date":"2021-09-24","current":105.881945,"twenty":-77.30512,"median":-6.716829,"eighty":-1.523573,"marketCap":1353806551},{"date":"2021-10-01","current":101.180345,"twenty":-77.30512,"median":-6.716829,"eighty":-1.517157,"marketCap":1293691897},{"date":"2021-10-08","current":108.088819,"twenty":-77.30512,"median":-6.716829,"eighty":-1.495908,"marketCap":1382023634},{"date":"2021-10-15","current":123.728834,"twenty":-77.30512,"median":-6.716829,"eighty":-1.484858,"marketCap":1581996872},{"date":"2021-10-22","current":124.73632,"twenty":-77.30512,"median":-6.716829,"eighty":-1.475257,"marketCap":1594878584},{"date":"2021-10-29","current":147.188857,"twenty":-77.30512,"median":-6.716829,"eighty":-1.460883,"marketCap":1881956729},{"date":"2021-11-05","current":163.980285,"twenty":-77.30512,"median":-6.716829,"eighty":-1.456578,"marketCap":2096651923},{"date":"2021-11-12","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.445734,"marketCap":2067208010},{"date":"2021-11-19","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.434782,"marketCap":2067208010},{"date":"2021-11-26","current":150.930947,"twenty":-77.30512,"median":-6.716829,"eighty":-1.432053,"marketCap":1929803086},{"date":"2021-12-03","current":138.697192,"twenty":-77.30512,"median":-6.716829,"eighty":92.966939,"marketCap":1773382302},{"date":"2021-12-10","current":116.804545,"twenty":-77.30512,"median":-6.716829,"eighty":99.366871,"marketCap":1638066942},{"date":"2021-12-17","current":114.169856,"twenty":-77.30512,"median":-6.716829,"eighty":101.093989,"marketCap":1601118064},{"date":"2021-12-23","current":129.714521,"twenty":-77.30512,"median":-6.716829,"eighty":102.54285,"marketCap":1819116446},{"date":"2021-12-31","current":128.133708,"twenty":-77.30512,"median":-6.716829,"eighty":106.764695,"marketCap":1796947119},{"date":"2022-01-07","current":97.527404,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1367724315},{"date":"2022-01-14","current":92.08238,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1291363300},{"date":"2022-01-21","current":79.918899,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1120782644},{"date":"2022-01-28","current":76.537715,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1073364917},{"date":"2022-02-04","current":85.056543,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192832957},{"date":"2022-02-11","current":93.180167,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1306758666},{"date":"2022-02-18","current":85.012631,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192217143},{"date":"2022-02-25","current":88.876842,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1246408831},{"date":"2022-03-04","current":81.148421,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1138025454},{"date":"2022-03-11","current":81.564879,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1147210023},{"date":"2022-03-18","current":96.139443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1352201265},{"date":"2022-03-25","current":94.690766,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1331825629},{"date":"2022-04-01","current":94.602968,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1330590742},{"date":"2022-04-08","current":83.057455,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1168203102},{"date":"2022-04-14","current":80.379598,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1130539048},{"date":"2022-04-22","current":75.418979,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1060767933},{"date":"2022-04-29","current":59.088443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":831078951},{"date":"2022-05-06","current":55.444802,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":779831140},{"date":"2022-05-13","current":54.96191,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":773039262},{"date":"2022-05-20","current":55.5765,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":781683471},{"date":"2022-05-27","current":60.449321,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":850219699},{"date":"2022-06-03","current":58.868947,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":827991733},{"date":"2022-06-10","current":55.620399,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":782300914},{"date":"2022-06-17","current":58.561652,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":823669629},{"date":"2022-06-24","current":68.52679,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":963829303},{"date":"2022-07-01","current":7.424698,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":947926104},{"date":"2022-07-08","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-15","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-22","current":8.48537,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1083344119},{"date":"2022-07-29","current":9.516981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1215052051},{"date":"2022-08-05","current":9.376527,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1197119985},{"date":"2022-08-12","current":9.536354,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1217525439},{"date":"2022-08-19","current":8.950321,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1142705440},{"date":"2022-08-26","current":8.930948,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1140232052},{"date":"2022-09-02","current":7.824981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":999030985},{"date":"2022-09-09","current":9.269592,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1139529431},{"date":"2022-09-16","current":8.637459,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1061820114},{"date":"2022-09-23","current":9.077423,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1115905799},{"date":"2022-09-30","current":9.669099,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1188641720},{"date":"2022-10-07","current":9.107766,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119635846},{"date":"2022-10-14","current":8.925711,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1097255563},{"date":"2022-10-21","current":7.868786,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":967325584},{"date":"2022-10-28","current":8.971225,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1102850633},{"date":"2022-11-04","current":6.928173,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851694119},{"date":"2022-11-11","current":7.767645,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":954892093},{"date":"2022-11-18","current":7.236653,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":889616266},{"date":"2022-11-25","current":7.438936,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":914483248},{"date":"2022-12-02","current":8.298636,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1020167920},{"date":"2022-12-09","current":6.812962,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":805660063},{"date":"2022-12-16","current":7.287183,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":861738490},{"date":"2022-12-23","current":7.202877,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851768992},{"date":"2022-12-30","current":7.255568,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":857999928},{"date":"2023-01-06","current":7.740326,"twenty":-77.30512,"median":-6.679923,"eighty":109.283255,"marketCap":915324542},{"date":"2023-01-13","current":8.593922,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1016265710},{"date":"2023-01-20","current":8.66769,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1024989021},{"date":"2023-01-27","current":8.636075,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1021250459},{"date":"2023-02-03","current":8.530693,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1008788586},{"date":"2023-02-10","current":8.699305,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1028727583},{"date":"2023-02-17","current":8.720381,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1031219957},{"date":"2023-02-24","current":8.620268,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1019381178},{"date":"2023-03-03","current":9.015451,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1066113200},{"date":"2023-03-10","current":7.350412,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":869215613},{"date":"2023-03-17","current":9.559254,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1113337596},{"date":"2023-03-24","current":9.382032,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1092697068},{"date":"2023-03-31","current":10.074809,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1173382770},{"date":"2023-04-06","current":10.203698,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1188394064},{"date":"2023-04-14","current":11.240179,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1309109882},{"date":"2023-04-21","current":10.289624,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1198401592},{"date":"2023-04-28","current":9.50555,"twenty":-77.30512,"median":-6.513848,"eighty":109.283255,"marketCap":1107082891},{"date":"2023-05-05","current":9.919068,"twenty":-77.30512,"median":-6.458489,"eighty":109.283255,"marketCap":1155244124},{"date":"2023-05-10","current":9.731105,"twenty":-77.30512,"median":-6.403131,"eighty":109.283255,"marketCap":1133352654},{"date":"2023-05-19","current":7.835366,"twenty":-77.358489,"median":-6.20015,"eighty":109.446474,"marketCap":912561547},{"date":"2023-05-26","current":8.168329,"twenty":-77.358489,"median":-6.107885,"eighty":109.446474,"marketCap":951340721},{"date":"2023-06-02","current":8.367032,"twenty":-77.358489,"median":-6.034074,"eighty":109.446474,"marketCap":974483132},{"date":"2023-06-09","current":9.194069,"twenty":-77.358489,"median":6.812962,"eighty":109.446474,"marketCap":1070805598},{"date":"2023-06-16","current":9.118884,"twenty":-77.385174,"median":6.991758,"eighty":109.528084,"marketCap":1062049010},{"date":"2023-06-23","current":1539.104598,"twenty":-77.386973,"median":7.174145,"eighty":110.625618,"marketCap":861898575},{"date":"2023-06-30","current":1496.538387,"twenty":-77.387872,"median":7.239761,"eighty":113.886744,"marketCap":838061497},{"date":"2023-07-07","current":1540.224762,"twenty":-77.387872,"median":7.287183,"eighty":118.166944,"marketCap":862525867},{"date":"2023-07-14","current":1497.65855,"twenty":-77.387872,"median":7.366219,"eighty":123.628937,"marketCap":838688788},{"date":"2023-07-21","current":1453.972175,"twenty":-77.387872,"median":7.424698,"eighty":125.174074,"marketCap":814224418},{"date":"2023-07-28","current":1438.289888,"twenty":-77.387872,"median":7.44905,"eighty":127.470924,"marketCap":805442337},{"date":"2023-08-04","current":1365.479263,"twenty":-77.387872,"median":7.624406,"eighty":129.89895,"marketCap":764668387},{"date":"2023-08-11","current":1437.169723,"twenty":-77.387872,"median":7.767645,"eighty":131.557258,"marketCap":804815045},{"date":"2023-08-18","current":1394.603513,"twenty":-77.387872,"median":7.840439,"eighty":132.799398,"marketCap":780977967},{"date":"2023-08-25","current":1319.552561,"twenty":-77.387872,"median":7.919356,"eighty":135.055715,"marketCap":738949434},{"date":"2023-09-01","current":1329.87968,"twenty":-77.387872,"median":8.066292,"eighty":136.461637,"marketCap":744732621},{"date":"2023-09-08","current":-236.80087,"twenty":-77.627134,"median":8.093067,"eighty":136.864886,"marketCap":733372293},{"date":"2023-09-15","current":-215.810775,"twenty":-79.724891,"median":8.093067,"eighty":136.864886,"marketCap":668365971},{"date":"2023-09-22","current":-193.597957,"twenty":-81.00567,"median":8.093067,"eighty":136.864886,"marketCap":599572873},{"date":"2023-09-29","current":-198.081278,"twenty":-81.501661,"median":8.093067,"eighty":136.864886,"marketCap":613457718},{"date":"2023-10-06","current":-191.356296,"twenty":-82.284183,"median":8.093067,"eighty":136.864886,"marketCap":592630450},{"date":"2023-10-13","current":-167.309392,"twenty":-83.104206,"median":8.093067,"eighty":136.864886,"marketCap":518157188},{"date":"2023-10-20","current":-142.039764,"twenty":-83.374176,"median":8.093067,"eighty":136.864886,"marketCap":439897149},{"date":"2023-10-27","current":-132.257973,"twenty":-83.539844,"median":8.114625,"eighty":137.082858,"marketCap":409602941},{"date":"2023-11-03","current":-125.125416,"twenty":-83.933555,"median":8.114625,"eighty":137.082858,"marketCap":387513414},{"date":"2023-11-10","current":-107.599706,"twenty":-84.748881,"median":8.114625,"eighty":137.082858,"marketCap":333236291},{"date":"2023-11-17","current":-105.561833,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":326924998},{"date":"2023-11-24","current":-111.87924,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":346490007},{"date":"2023-12-01","current":-103.727747,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":321244834},{"date":"2023-12-08","current":-29.21466,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":334507860},{"date":"2023-12-15","current":-32.03385,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":366787580},{"date":"2023-12-22","current":-35.402927,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":405363515},{"date":"2023-12-29","current":-37.501697,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":429394426},{"date":"2024-01-05","current":-33.911696,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":388288921},{"date":"2024-01-12","current":-37.336004,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":427497248},{"date":"2024-01-19","current":-33.746004,"twenty":-87.127444,"median":8.138341,"eighty":137.475209,"marketCap":386391744},{"date":"2024-01-26","current":-38.219697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":437615526},{"date":"2024-02-02","current":-36.397081,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":416746578},{"date":"2024-02-09","current":-36.562773,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":418643755},{"date":"2024-02-16","current":-42.527697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":486942132},{"date":"2024-02-23","current":-44.12939,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":505281511},{"date":"2024-03-01","current":-42.417236,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":485677347},{"date":"2024-03-08","current":-33.690773,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":385759351},{"date":"2024-03-15","current":-33.635542,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":385126959},{"date":"2024-03-22","current":-37.943543,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":434453565},{"date":"2024-03-28","current":-38.551081,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":441409881},{"date":"2024-04-05","current":-35.016312,"twenty":-84.693001,"median":8.125366,"eighty":137.279033,"marketCap":400936768},{"date":"2024-04-12","current":-38.109235,"twenty":-83.840428,"median":8.125366,"eighty":137.279033,"marketCap":436350742},{"date":"2024-04-19","current":-36.010466,"twenty":-83.520355,"median":8.125366,"eighty":137.279033,"marketCap":412319831},{"date":"2024-04-26","current":-26.277899,"twenty":-83.301704,"median":8.114625,"eighty":137.082858,"marketCap":464672092},{"date":"2024-05-03","current":-29.436991,"twenty":-82.558967,"median":8.114625,"eighty":137.082858,"marketCap":520534310},{"date":"2024-05-10","current":-29.221598,"twenty":-82.027926,"median":8.114625,"eighty":137.082858,"marketCap":516725523},{"date":"2024-05-17","current":-33.026868,"twenty":-81.364604,"median":8.114625,"eighty":137.082858,"marketCap":584014104},{"date":"2024-05-24","current":-31.698613,"twenty":-80.745541,"median":8.114625,"eighty":137.082858,"marketCap":560526581},{"date":"2024-05-31","current":-28.539522,"twenty":-79.544946,"median":8.114625,"eighty":137.082858,"marketCap":504664362},{"date":"2024-06-07","current":-28.826712,"twenty":-77.386073,"median":8.114625,"eighty":137.082858,"marketCap":509742745},{"date":"2024-06-14","current":-24.770151,"twenty":-75.623994,"median":8.125366,"eighty":137.279033,"marketCap":438010578},{"date":"2024-06-21","current":-24.447062,"twenty":-74.423568,"median":8.138341,"eighty":137.475209,"marketCap":432297397},{"date":"2024-06-28","current":-25.165037,"twenty":-73.302439,"median":8.168329,"eighty":137.998343,"marketCap":444993355},{"date":"2024-07-05","current":-3.47825,"twenty":-72.208373,"median":8.168329,"eighty":137.998343,"marketCap":489574115},{"date":"2024-07-12","current":-3.613766,"twenty":-71.674682,"median":8.168329,"eighty":137.998343,"marketCap":508648432},{"date":"2024-07-15","current":-3.758317,"twenty":-71.647997,"median":8.168329,"eighty":137.998343,"marketCap":528994369},{"date":"2024-08-02","current":-4.729516,"twenty":-70.687354,"median":8.235305,"eighty":139.297726,"marketCap":665693635},{"date":"2024-08-09","current":-4.774689,"twenty":-70.233717,"median":8.235305,"eighty":139.297726,"marketCap":672051740},{"date":"2024-08-16","current":-4.824378,"twenty":-69.886817,"median":8.235305,"eighty":139.297726,"marketCap":679045656},{"date":"2024-08-23","current":-4.810826,"twenty":-69.379811,"median":8.235305,"eighty":139.297726,"marketCap":677138225},{"date":"2024-08-30","current":-4.695582,"twenty":-68.84612,"median":8.235305,"eighty":139.297726,"marketCap":660917318},{"date":"2024-09-06","current":-4.079174,"twenty":-68.285745,"median":8.235305,"eighty":139.297726,"marketCap":574155972},{"date":"2024-09-13","current":-4.938462,"twenty":-67.912161,"median":8.235305,"eighty":139.297726,"marketCap":711953405},{"date":"2024-09-20","current":-5.509306,"twenty":-66.964853,"median":8.235305,"eighty":139.297726,"marketCap":794249094},{"date":"2024-09-27","current":-4.942887,"twenty":-65.87829,"median":8.235305,"eighty":139.297726,"marketCap":712591356},{"date":"2024-10-04","current":-4.672953,"twenty":-64.235019,"median":8.235305,"eighty":139.297726,"marketCap":673676340},{"date":"2024-10-11","current":-4.500373,"twenty":-63.139506,"median":8.235305,"eighty":139.297726,"marketCap":648796248},{"date":"2024-10-18","current":-4.491523,"twenty":-61.770113,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-10-25","current":-4.518073,"twenty":-60.358586,"median":8.235305,"eighty":139.297726,"marketCap":651348052},{"date":"2024-10-31","current":-4.491523,"twenty":-59.28414,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-11-08","current":-5.416378,"twenty":-57.72514,"median":8.243207,"eighty":139.447859,"marketCap":780852121},{"date":"2024-11-15","current":-5.292495,"twenty":-55.723721,"median":8.243207,"eighty":139.447859,"marketCap":762992503},{"date":"2024-11-22","current":-5.434456,"twenty":-53.82764,"median":8.243207,"eighty":139.447859,"marketCap":783458354},{"date":"2024-11-29","current":-5.447765,"twenty":-50.035478,"median":8.243207,"eighty":139.447859,"marketCap":785377027},{"date":"2024-12-06","current":-5.452201,"twenty":-48.666086,"median":8.243207,"eighty":139.447859,"marketCap":786016585},{"date":"2024-12-13","current":-5.178482,"twenty":-47.296694,"median":8.243207,"eighty":139.447859,"marketCap":787388247},{"date":"2024-12-20","current":-5.186896,"twenty":-46.111834,"median":8.243207,"eighty":139.447859,"marketCap":788667513},{"date":"2024-12-27","current":-5.165862,"twenty":-45.841544,"median":8.243207,"eighty":139.447859,"marketCap":785469348},{"date":"2025-01-03","current":-5.182689,"twenty":-45.510159,"median":8.243207,"eighty":139.447859,"marketCap":788027880},{"date":"2025-01-10","current":-5.207929,"twenty":-44.898573,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-17","current":-5.207929,"twenty":-44.137114,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-24","current":-5.237377,"twenty":-43.29527,"median":8.253213,"eighty":139.458758,"marketCap":796343109},{"date":"2025-01-31","current":-5.241583,"twenty":-42.152128,"median":8.253213,"eighty":139.458758,"marketCap":796982742},{"date":"2025-02-04","current":-5.249997,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"marketCap":798262008}],"updateTime":1746659627222}}}